
Nguồn ngoài
VTCSOM Block V Preparation Materials
- Tác giả
- Renée LeClair
- Nhà xuất bản
- Virginia Tech Carilion School of Medicine
- Nguồn
- LibreTexts
- Giấy phép
- CC BY-NC-SA
- Ngôn ngữ
- EN
Mục lục· 429 mục
- 01: Basic Microbiology and Infection Control
- 1.01: Classification - The Three Domain System
- 1.02: Sizes Shapes and Arrangements of Bacteria
- 1.03: The Peptidoglycan Cell Wall
- 1.3.01: Damage of the Cell Wall
- 1.3A: The Gram-Positive Cell Wall
- 1.3B: The Gram-Negative Cell Wall
- 1.3C: The Acid-Fast Cell Wall
- 1.04: Structures Outside the Cell Wall
- 1.4A: Glycocalyx (Capsules) and Biofilms
- 1.4B: Flagella
- 1.4C: Fimbriae and Pili
- 1.05: Cellular Components within the Cytoplasm
- 1.5A: Cytoplasm
- 1.5B: The Bacterial Chromosome and Nucleoid
- 1.5C: Plasmids and Transposons
- 1.5D: Ribosomes
- 1.5E: Endospores
- 1.5F: Inclusion Bodies and Organelles Used for Photosynthesis
- 1.06: An Overview to Control of Microorganisms
- 1.07: Ways in which Chemical Control Agents Affect Bacteria
- 1.08: Ways in which Bacteria May Resist Chemical Control Agents
- 02: Pathogenicity
- 2.01: Overview of Microbe-Host Interactions
- 2.1A: Normal Microbiota and Host Relationships
- 2.1B: Opportunistic Microorganisms
- 2.1C: Cooperation Among Microorganisms
- 2.02: Penetrating Host Defenses
- 2.2A: Penetrating Host Defenses
- 2.2B: Pili and Pilus Assembly
- 2.2C: Biofilms and Infections
- 2.03: Damaging Host Cells
- 2.3A: Toxins
- 2.3B: Direct Damage
- 2.3C: Type III and Type IV Secretion
- 2.3D: Plasmids and Lysogeny
- 2.3E: Siderophores
- 2.04: Surviving Within the Host and Exiting the Host
- 2.4A: Intracellular Pathogens
- 2.4B: Extracellular Immune Avoidance
- 2.4C: Regulating Virulence
- 2.4D: Portals of Exit
- 2.05: Pathogenicity and Other Microbes
- 2.5A: Fungi
- 2.5B: Protozoa
- 2.5C: Helminths
- 2.5D: Algae
- 03: Bacteria
- 3.01: Clostridium tetani
- 3.02: Escherichia coli
- 3.03: Haemophilus influenzae
- 3.04: Helicobacter pylori
- 3.05: Neisseria gonorrhoeae
- 3.06: Neisseria meningitidis
- 3.07: Staphylococcus aureus
- 3.08: Streptococcus pneumoniae
- 3.09: Streptococcus pyogenes
- 3.10: Vibrio cholerae
- 04: Culturing Bacteria
- 4.01: Culture Media
- 4.02: Complex and Synthetic Media
- 4.03: Selective and Differential Media
- 4.04: Aseptic Technique Dilution Streaking and Spread Plates
- 4.05: Special Culture Techniques
- 05: Entry into the Host
- 5.01: Portals of Microbe Entry
- 5.02: Colonization and Growth
- 5.03: Pathogenicity Islands and Virulence Factors
- 5.04: Adherence
- 5.05: Host Risk Factors
- 5.06: Innate Resistance
- 06: Bacterial Infections
- 6.01: Bacterial Diseases of the Respiratory System
- 6.1A: Pharyngitis
- 1.01: Scarlet Fever
- 6.1C: Diphtheria
- 6.1D: Otitis Media
- 6.1E: Whooping Cough
- 6.1F: Tuberculosis
- 6.1G: Bacterial Pneumonias
- 6.02: Bacterial Diseases of the Mouth
- 6.2A: Tooth and Gum Infections
- 6.2B: Dental Caries
- 6.2C: Periodontal Disease
- 6.03: Bacterial Diseases of the Digestive System
- 6.3A: Bacterial Gastroenteritis
- 6.3B: Staphylococcal Food Poisoning
- 6.3C: Salmonellosis
- 6.3D: Typhoid Fever
- 6.3E: Cholera
- 6.3F: Noncholera Vibrios
- 6.3G: Pathogenic Escherichia coli
- 6.3H: Campylobacter
- 6.3I: Peptic Ulcer Disease
- 6.3J: Listeriosis
- 6.04: Bacterial Diseases of the Urinary System
- 6.4A: Urinary Tract Infection (UTI)
- 6.4B: Cystitis
- 6.4C: Pyelonephritis
- 6.4D: Leptospirosis
- 6.05: Bacterial Diseases of the Reproductive System
- 6.5A: Prostatitis
- 6.5B: Prostatitis
- 6.5C: Gonorrhea
- 6.5D: Nongonococcal Urethritis (NGU)
- 6.5E: Pelvic Inflammatory Disease (PID)
- 6.5F: Syphilis
- 6.5G: Genital Ulcer Diseases
- 6.5H: Lymphogranuloma Venereum
- 6.5I: Group B Streptococcus Colonization
- 6.5J: Chancroid (Soft Chancre)
- 6.5K: Bacterial Vaginosis
- 6.5L: Chlamydia
- 6.06: Microbial Diseases of the Skin
- 6.6A: Structure of the Skin- Epidermis
- 6.6B: Microbiota of the Skin
- 6.6C: Bacterial Skin Diseases
- 6.6D: Viral Skin Diseases
- 6.6E: Fungal Skin and Nail Diseases
- 6.6F: Parasitic Skin Diseases
- 6.07: Microbial Diseases of the Eye
- 6.7A: Anatomy of the Eye
- 6.7B: Normal Eye Microbiota
- 6.7C: Bacterial Eye Diseases
- 6.7D: Other Infectious Eye Diseases
- 6.08: Microbial Diseases of the Nervous System
- 6.8A: Functions of the Nervous System
- 6.8B: Subdivisions of the Nervous System
- 6.8C: Meningitis
- 6.8D: Botulism
- 6.8E: Leprosy
- 6.8F: Tetanus
- 6.8G: Paralysis-Causing Bacterial Neurotoxins
- 07: Innate Nonspecific Host Defenses
- 7.01: Physical Defenses
- 7.02: Chemical Defenses
- 7.03: Cellular Defenses
- 7.04: Pathogen Recognition and Phagocytosis
- 08: Basic Immunology Review
- 8.01: Overview of the Immune System
- 8.02: Anatomical Barriers to Infection Mechanical Removal of Microbes and Bacterial Antagonism by Normal Body Microbiota
- 8.03: Cells and Organs of the Immune System
- 8.04: Antimicrobial Enzymes and Antimicrobial Peptides
- 8.05: The Complement System
- 09: Innate Immunity
- 9.01: Overview of Immunity
- 9.02: The Innate Immune Response
- 9.03: The Innate Immune System- An Overview
- 9.04: Overview of Human-Microbial Reactions
- 9.05: Natural Killer Cells
- 9.06: Physical and Chemical Barriers
- 9.07: The Complement System
- 9.08: Pathogen Recognition
- 9.09: Defense Cells in the Blood- The Leukocytes
- 9.10: Defense Cells in the Tissue - Dendritic Cells Macrophages and Mast Cells
- 9.11: Early Induced Innate Immunity
- 9.11A: Pathogen-Associated Molecular Patterns (PAMPs) and Danger-Associated Molecular Patterns (DAMPs)
- 9.11B: Pattern-Recognition Receptors (PRRs)
- 9.11C: Cytokines Important in Innate Immunity
- 9.11D: Harmful Effects Associated with Abnormal Pattern-Recognition Receptor Responses Variations in Innate Immune Signaling Pathways and or Levels of Cytokine Production
- 9.11E: Phagocytosis
- 9.11F: Natural Killer Cells (NK Cells) and Invariant Natural Killer T-Lymphocytes (iNKT Cells)
- 9.11G: Inflammation
- 9.11H: Nutritional Immunity
- 9.11I: Fever
- 9.11J: The Acute Phase Response
- 9.11K: Intraepithelial T-lymphocytes and B-1 cells
- 10: Adaptive Immunity
- 10.01: Immunodeficiency
- 10.1.E: Immunodeficiency (Exercises)
- 10.02: Hypersensitivities
- 10.2.E: Hypersensitivities (Exercises)
- 10.03: Introduction to Adaptive Immunity
- 10.3.01: An Overview of Innate and Adaptive Immunity
- 10.3.02: Antigens and Epitopes
- 10.3.03: Major Cells and Key Cell Surface Molecules Involved in Adaptive Immune Responses
- 10.3.3A: Major Histocompatibility Complex (MHC) Molecules
- 10.3.3B: Antigen-Presenting Cells (APCs)
- 10.3.3C: T4-Lymphocytes (T4-Cells)
- 10.3.3D: T8-Lymphocytes (T8-Cells)
- 10.3.3E: Invarient Natural Killer T-Lymphocytes (iNKT Cells)
- 10.3.3F: B-Lymphocytes (B-Cells)
- 10.3.3G: Natural Killer Cells (NK Cells)
- 10.3.04: The Lymphoid System
- 10.3.05: An Overview of the Steps Involved in Adaptive Immune Responses
- 10.3.E: Introduction to Adaptive Immunity (Exercises)
- 10.04: Humoral Immunity
- 10.4.01: Antibodies (Immunoglobulins)
- 10.4.1B: Antibody Structure
- 10.4.1C: The 5 Classes (Isotypes) of Human Antibodies
- 10.4.1D: Generation of Antibody Diversity
- 10.4.1E: Clonal Selection and Clonal Expansion
- 10.4.1F: Anamnestic (Memory) Response
- 10.4.02: Ways That Antibodies Help to Defend the Body
- 10.4.2A: Opsonization
- 10.4.2B: Cytolysis by the Membrane Attack Complex (MAC)
- 10.4.2C: Antibody-dependent Cellular Cytotoxicity (ADCC) by Natural Killer Cells
- 10.4.2D: Neutralization of Exotoxins
- 10.4.2E: Neutralization of Viruses
- 10.4.2F: Preventing Bacterial Adherence
- 10.4.2G: Agglutination of Microorganisms
- 10.4.2H: Immobilization of Bacteria and Protozoans
- 10.4.2I: Promoting an Inflammatory Response
- 10.4.03: Naturally and Artificially Acquired Active and Passive Immunity
- 10.4.3A: Naturally Acquired Immunity
- 10.4.3B: Artificially Acquired Immunity
- 10.4.E: Humoral Immunity (Exercises)
- 10.05: Cell-Mediated Immunity
- 10.5.01: Cell-Mediated Immunity - An Overview
- 10.5.02: Activating Antigen-Specific Cytotoxic T- Lymphocytes
- 10.5.03: Activating Macrophages and NK Cells
- 10.5.04: Stimulating Cells to Secrete Cytokines
- 10.5.E: Cell-Mediated Immunity (Exercises)
- 11: Specific Adaptive Host Defenses
- 11.01: Architecture of the Immune System
- 11.02: Antigens Antigen Presenting Cells and Major Histocompatibility Complexes
- 11.03: T Lymphocytes
- 11.04: B Lymphocytes and Antibodies
- 12: Hypersensitivities
- 12.01: Type I (Anaphylactic) Reactions
- 12.02: Diagnosis and Treatment of Allergy
- 12.03: Type II (Cytotoxic) Reactions
- 12.04: Type III (Immune Complex) Reactions
- 12.05: Type IV (Delayed Cell-Mediated) Reactions
- 12.06: Immunity Disorders- Hypersensitivity
- 13: Laboratory Analysis of the Immune Response
- 13.01: Practical Applications of Monoclonal and Polyclonal Antibodies
- 13.02: Detecting Antigen-Antibody Complexes in vitro
- 13.03: Agglutination Assays
- 13.04: Enzyme Immunoassays (EIA) and Enzyme-Linked Immunosorbent Assays (ELISA)
- 13.05: Fluorescent Auto-Antibody Techniques
- 13.E: Laboratory Analysis of the Immune Response (Exercises)
- 14: Immunodeficiencies
- 14.01: Immunity Disorders- Autoimmune Diseases
- 14.1A: Immunodeficiency
- 14.02: Autoimmune Disorders
- 14.03: Superantigens
- 14.04: Immunity Disorders- Immunodeficiencies
- 14.05: Cell-Mediated Autoimmune Reactions
- 14.06: Immune Complex Autoimmune Reactions
- 14.07: Cytotoxic Autoimmune Reactions
- 14.08: Primary Immunodeficiency
- 14.09: Primary Immunodeficiency Diseases
- 14.10: Secondary Immunodeficiency
- 14.11: Secondary Immunodeficiency Diseases
- 14.12: Immunotherapy for Cancer
- 14.13: The Roles of Genetics and Gender in Autoimmune Disease
- 15: Acellular Pathogens
- 15.01: Viruses
- 15.02: The Viral Life Cycle
- 15.03: Isolation Culture and Identification of Viruses
- 15.04: Viroids Virusoids and Prions
- 15.05: Viral Replication
- 15.5A: General Features of Virus Replication
- 15.5B: Steps of Virus Infections
- 15.5C: Tissue Tropism in Animal Viruses
- 15.5D: Animal Viruses
- 15.5E: Plant Virus Life Cycles
- 15.06: Viral Diversity
- 15.6A: Overview of Bacterial Viruses
- 15.6B: RNA Bacteriophages
- 15.6C: Single-Stranded DNA Bacteriophages
- 15.6D: Double-Stranded DNA Bacteriophages
- 15.6E: Mu- A Double-Stranded Transposable DNA Bacteriophage
- 15.6F: Virulent Bacteriophages and T4
- 15.6G: Temperate Bacteriophages - Lambda and P1
- 15.6H: Viruses of Archaea
- 15.07: Positive-Strand RNA Viruses in Animals
- 15.7A: Positive-Strand RNA Viruses of Animals
- 15.7B: Virus Attachment and Genome Entry
- 15.7C: Viral Replication and Gene Expression
- 15.7D: Viral Exit
- 15.08: Retroviruses- Double-Stranded RNA Viruses
- 15.8A: Double-Stranded RNA Viruses - Retroviruses
- 15.8B: HIV Attachment and Host Cell Entry
- 15.8C: Retroviral RNA Genome
- 15.8D: Replicative Cycle of HIV
- 15.09: Negative-Strand RNA Viruses in Animals
- 15.9.01: Negative-Strand RNA Viruses of Animals
- 15.9.02: Attachment and Entry to the Host Cell
- 15.9.03: Replicative Cycle of Influenza A
- 15.10: DNA Viruses in Eukaryotes
- 15.10.01: Plant DNA Viruses
- 15.10.02: Replication of Double-Stranded DNA Viruses of Animals
- 15.10.03: Double-Stranded DNA Viruses - Herpesviruses
- 15.10.04: Attachment and Entry of Herpes Simplex
- 15.10.05: Replication of Herpes Simplex Virus
- 15.10.06: Immunodeficiency
- 15.10.07: Double-Stranded DNA Viruses - Pox Viruses
- 15.10.08: Double-Stranded DNA Viruses- Adenoviruses
- 15.10.09: Retroviruses and Hepadnavirus
- 15.10.10: Treatment of Animal Viral Infections
- 15.11: Viruses and Cancer
- 15.11.01: Cancer Viruses
- 15.11.02: DNA Oncogenic Viruses
- 15.11.03: RNA Oncogenic Viruses
- 15.12: Overview of Viruses
- 15.12.01: Discovery and Detection of Viruses
- 15.12.02: Nature of the Virion
- 15.12.03: Viral Genomes
- 15.12.04: Host Range
- 15.12.05: Viral Size
- 15.13: Structure of Viruses
- 15.13A: Viral Morphology
- 15.13B: General Morphology
- 15.13C: Complex and Asymmetrical Virus Particles
- 15.14: Classifying Viruses
- 15.14.01: The International Committee on Taxonomy of Viruses
- 15.14.02: The Baltimore Virus Classification
- 15.14.03: Evolution of Viruses
- 15.14.04: Medical Importance of Viruses
- 15.15: Culturing Viruses
- 15.15A: Batch Culture of Bacteriophages
- 15.15B: Tissue Culture of Animal Viruses
- 15.15C: Inoculation of Live Animals
- 15.15D: Viral Identification
- 15.16: Subviral Entities
- 15.16A: Defective Viruses
- 15.16B: Viroids
- 15.16C: Prions
- 15.17: Viral Ecology
- 15.17A: Emergence of Viral Pathogens
- 15.17B: Viral Roles in Ecosystems
- 16: The Eukaryotes of Microbiology
- 16.01: Unicellular Eukaryotic Microorganisms
- 16.02: Parasitic Helminths
- 16.03: Fungi
- 16.04: Algae
- 16.05: Lichens
- 16.E: The Eukaryotes of Microbiology (Exercises)
- 17: Systemic Infections
- 17.01: Respiratory System Infections
- 17.1.01: Anatomy and Normal Microbiota of the Respiratory Tract
- 17.1.02: Bacterial Infections of the Respiratory Tract
- 17.1.03: Viral Infections of the Respiratory Tract
- 17.1.04: Respiratory Mycoses
- 17.1.E: Respiratory System Infections (Exercises)
- 17.02: Urogenital System Infections
- 17.2.01: Anatomy and Normal Microbiota of the Urogenital Tract
- 17.2.02: Bacterial Infections of the Urinary System
- 17.2.03: Bacterial Infections of the Reproductive System
- 17.2.04: Viral Infections of the Reproductive System
- 17.2.05: Fungal Infections of the Reproductive System
- 17.2.06: Protozoan Infections of the Reproductive System
- 17.2.E: Urogenital System Infections (Exercises)
- 17.03: Digestive System Infections
- 17.3.01: Anatomy and Normal Microbiota of the Digestive System
- 17.3.02: Microbial Diseases of the Mouth and Oral Cavity
- 17.3.03: Bacterial Infections of the Gastrointestinal Tract
- 17.3.04: Viral Infections of the Gastrointestinal Tract
- 17.3.05: Protozoan Infections of the Gastrointestinal Tract
- 17.3.06: Helminthic Infections of the Gastrointestinal Tract
- 17.3.E: Digestive System Infections (Exercises)
- 17.04: Circulatory and Lymphatic System Infections
- 17.4.01: Anatomy of the Circulatory and Lymphatic Systems
- 17.4.02: Bacterial Infections of the Circulatory and Lymphatic Systems
- 17.4.03: Viral Infections of the Circulatory and Lymphatic Systems
- 17.4.04: Parasitic Infections of the Circulatory and Lymphatic Systems
- 17.4.E: Circulatory and Lymphatic System Infections (Exercises)
- 17.05: Nervous System Infections
- 17.5.01: Anatomy of the Nervous System
- 17.5.02: Bacterial Diseases of the Nervous System
- 17.5.03: Acellular Pathogenic Diseases of the Nervous System
- 17.5.04: Neuromycoses and Parasitic Diseases of the Nervous System
- 17.5.E: Nervous System Infections (Exercises)
- 17.06: Fungal Diseases of the Respiratory System
- 17.6.01: Histoplasmosis
- 17.6.02: Coccidiomycosis
- 17.6.03: Pneumocystis Pneumonia
- 17.6.04: Blastomycosis
- 17.6.05: Other Fungi Involved in Respiratory Disease
- 17.07: Fungal and Protozoan Diseases of the Digestive System
- 17.7.01: Ergot Poisoning
- 17.7.02: Aflatoxin Poisoning
- 17.7.03: Giardiasis
- 17.7.04: Cryptosporidiosis
- 17.7.05: Cyclospora Diarrheal Infection
- 17.7.06: Amoebic Dysentery (Amoebiasis)
- 17.7.07: Legionellosis
- 17.08: Helminthic Diseases of the Digestive System
- 17.8.01: Tapeworms
- 17.8.02: Hydatid Disease
- 17.8.03: Nematodes
- 17.09: Fungal and Protozoan Diseases of the Reproductive System
- 17.9.01: Vulvovaginal Candidiasis
- 17.9.02: Trichomoniasis
- 17.9.03: The TORCH Panel of Tests
- 17.10: Fungal Skin and Nail Diseases
- 17.11: Parasitic Skin Diseases
- 17.12: Other Infectious Eye Diseases
- 17.13: Fungal Protozoan Prion and Other Diseases of the Nervous System
- 17.13.01: Cryptococcosis
- 17.13.02: African Trypanosomiasis
- 17.13.03: Amoebic Meningoencephalitis
- 17.13.04: Bovine Spongiform Encephalopathy
- 17.13.05: Variant Creutzfeldt-Jakob Disease
- 17.13.06: Chronic Fatigue Syndrome
- 18: Immunization
- 18.01: Passive Immunization
- 18.02: Vaccination
- 18.03: Types of Vaccines
- 18.04: Development of New Vaccines
- 18.05: Vaccine Safety
- 19: Vaccine Safety
- 19.01: Non-Severe Events
- 19.02: Anaphylaxis
- 19.03: Vaccine Facts
- 19.04: Self Assessment
- 19.05: Vaccine Safety
- 19.06: Evaluation of Vaccines Pre-License
- 19.07: Canada Vigilance Program
- 19.08: Reflective Questions
- 19.09: Key Takeaways
- 19.10: References
- 20: Human Health and Disease
- 20.01: Human Health and Disease
- 20.02: The Gut Microbiome
- 20.03: The Oral Microbiome
- 20.04: The Skin Microbiome
- 20.05: The Respiratory Microbiome
- 20.06: The Vaginal Microbiome
- 20.07: Mental Health and Multi-Microbiome Interactions
- 21: Cancer Immunobiology and Immunotherapy
- 22: Skin and Eye Infections
- 22.01: Anatomy and Normal Microbiota of the Skin and Eyes
- 22.02: Bacterial Infections of the Skin and Eyes
- 22.03: Viral Infections of the Skin and Eyes
- 22.04: Mycoses of the Skin and Eyes
- 22.05: Protozoan and Helminthic Infections of the Eyes